《流感快速免疫检测计划（Flu-FIT）在患者协作护理团队中的应用：一项质量改进项目》。

Adaptation of the Flu-FIT Program for Patient-Aligned Care Teams: A Quality Improvement Project.

机构信息

Department of Medicine (Drs Friedman, Korenblit, and Thomas), Rutgers New Jersey Medical School, Newark, New Jersey (Dr Funes and Ms Flores); Department of Biostatistics & Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey (Dr Davidow); and VA New Jersey Healthcare System, East Orange, New Jersey (Dr Korenblit).

出版信息

J Public Health Manag Pract. 2021;27(Suppl 3):S159-S163. doi: 10.1097/PHH.0000000000001313.

DOI:10.1097/PHH.0000000000001313

PMID:33785689

Abstract

The Flu-FIT program aims to increase colorectal cancer screening rates by offering a home fecal immunochemical test (FIT) at the time of annual influenza immunization. This program was piloted at a VA campus in New Jersey during the 2018-2019 influenza season, with a 9% increase in colorectal cancer screening rates. In the 2019-2020 season, the program was implemented in 6 primary care teams; 6 additional teams maintaining standard of care served as a comparison group. A total of 816 patients aged 50 to 75 years were eligible for participation; 509 patients were available for analysis, 242 in the Flu-FIT group and 267 in the comparison group. The Flu-FIT group patients were 2.4 times more likely to accept FIT kits (95% confidence interval: 1.6-3.6, P = .001). The colorectal cancer screening rates increased 77.0% to 81.9% in the Flu-FIT group and 77.0% to 79.8% in the comparison group (P > .05).

摘要

流感-FIT 计划旨在通过在年度流感免疫接种时提供家用粪便免疫化学测试（FIT）来提高结直肠癌筛查率。该计划在新泽西州的一个退伍军人事务部园区进行了试点，在 2018-2019 年流感季节，结直肠癌筛查率提高了 9%。在 2019-2020 赛季，该计划在 6 个初级保健团队中实施；另外 6 个维持标准护理的团队作为对照组。共有 816 名年龄在 50 至 75 岁之间的患者符合参与条件；共有 509 名患者可进行分析，其中 Flu-FIT 组 242 名，对照组 267 名。Flu-FIT 组的患者接受 FIT 试剂盒的可能性高 2.4 倍（95%置信区间：1.6-3.6，P=0.001）。Flu-FIT 组的结直肠癌筛查率从 77.0%增加到 81.9%，对照组从 77.0%增加到 79.8%（P>0.05）。